(Date:12/11/2009)... a new explanation for differences in the severity of mental ... gene, the more serious the handicap. The genetic defect is ... is the amount of copies of the GDI1 gene that ... American Journal of Human Genetics , and are the result ... VIB, a life sciences research institute in Flanders, Belgium at ...
(Date:12/11/2009)... Algeta ASA (OSE: ALGETA), the,cancer ... center in the,US, the Tulane Cancer Center, ... phase III clinical study of Alpharadin in ... cancer,(CRPC) that has metastasized to the skeleton. ... (ALpharadin in SYMptomatic Prostate CAncer) study is ...
(Date:12/11/2009)... Inc. (TSX:ONC, NASDAQ: ONCY ) ("Oncolytics" or the ... Warrander to the role of Senior Vice President, ... will be responsible for the execution of the ... Thompson, President and CEO of Oncolytics. "Having reached ... 3 trial examining REOLYSIN in combination with paclitaxel ...
(Date:12/10/2009)... HUNTERSVILLE, N.C., Dec. 10 Microban ... antimicrobial product protection, has partnered with Sharp ... division of Sharp Electronics, to incorporate it,s ... new printing calculators. Infused into the calculator ... protection inhibits the growth of damaging bacteria ...
Breaking Biology Technology:Amount of gene surplus determines severity of mental retardation in males 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3Microban Signs Exclusive Agreement with Sharp Electronics to Launch Calculators with New Microban(R) 3G Silver(TM) Antimicrobial Technology 2... YORK, March 12 Biotechnology Value Fund, L.P. ("BVF"), today ... of Avigen, Inc. (Nasdaq: AVGN ) urging stockholders ... replace them with BVF,s four new, stockholder-oriented, independent director nominees ... March 27, 2009. BVF, the beneficial owner of approximately ...
... PALO ALTO, Calif., March 12 The Board of Directors ... today that after careful consideration of Astellas Pharma Inc.,s $16.00 ... advisors, it has determined that Astellas, offer undervalues the Company ... Accordingly, the Board of Directors recommends that stockholders not ...
... Challenge Sought Ideas to Encourage Investment and Collaboration in ... 12 InnoCentive, Inc., the global open ... Center for Accelerating Medical Solutions , today announced that ... solutions they submitted to a Challenge that FasterCures ...
Other Biology Technology:Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 2Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 3Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 4Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 5Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 6Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 7Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 8Biotechnology Value Fund Urges Stockholders to Remove and Replace Current Board of Avigen, Inc. in an Effort to Protect and Maximize Stockholder Value 9CV Therapeutics' Board of Directors Rejects Astellas' Tender Offer 2CV Therapeutics' Board of Directors Rejects Astellas' Tender Offer 3FasterCures Rewards Two InnoCentive Solvers for Innovative Ideas to Accelerate Medical Research 2FasterCures Rewards Two InnoCentive Solvers for Innovative Ideas to Accelerate Medical Research 3FasterCures Rewards Two InnoCentive Solvers for Innovative Ideas to Accelerate Medical Research 4FasterCures Rewards Two InnoCentive Solvers for Innovative Ideas to Accelerate Medical Research 5... Hawkins was a 19th-century British artist and naturalist who ... and its pre-human inhabitants. Hawkins drew worldwide attention in ... dinosaur skeleton, Hadrosaurus foulkii , at The Academy ... prepares to remount a cast of Hadrosaurus in November, ...
... Identified, A Potential Metastatic Disease Target? , Researchers ... of cancer stem cell that might initiate metastatic cancer, ... to other locations within the body. For the first ... these cancer stem cells are much different than those ...
... with autism evaluate facial expressions differently than the rest ... strikingly similar to autistic patients themselves, according to new ... of North Carolina at Chapel Hill and neuroscientist Ralph ... , Piven, Adolphs and colleague Michael Spezio, Ph.D., formerly ...
Other Biology News:Academy publishes first biography of artist-naturalist Benjamin Waterhouse Hawkins 2Academy publishes first biography of artist-naturalist Benjamin Waterhouse Hawkins 3Weill Cornell science briefs June/July 2008 2Weill Cornell science briefs June/July 2008 3Weill Cornell science briefs June/July 2008 4Weill Cornell science briefs June/July 2008 5Weill Cornell science briefs June/July 2008 6Weill Cornell science briefs June/July 2008 7UNC, Caltech research finds further evidence for genetic contribution to autism 2UNC, Caltech research finds further evidence for genetic contribution to autism 3MOUSE ANTI GUINEA PIG T-CELLS (PAN):FITC Immunogen: Guinea pig peritoneal T-cells...
Prepared in 0.85% saline....
RABBIT ANTI HUMAN CYTOCHROME P450 1A1/2 Immunogen: Purified human CYP1A2 expressed in E.Coli ...
SHEEP ANTI HUMAN ESTRONE...
Biology Products:Biology NavigationMedical Navigation